Bio-Techne (TECH) EBIT Margin Growth (5y) (2014 - 2026)

Bio-Techne (TECH) EBIT Margin Growth (5y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Bio-Techne 11.33 Bn 11.12 Bn 208.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -393.00
Dec 31, 2025 -433.00
Sep 30, 2025 -741.00
Jun 30, 2025 -2,988.00
Mar 31, 2025 -1,231.00
Dec 31, 2024 -404.00
Sep 30, 2024 -437.00
Jun 30, 2024 -760.00
Mar 31, 2024 -177.00
Dec 31, 2023 -531.00
Sep 30, 2023 436.00
Jun 30, 2023 756.00
Mar 31, 2023 99.00
Dec 31, 2022 933.00
Sep 30, 2022 279,785.00
Jun 30, 2022 238.00
Mar 31, 2022 789.00
Dec 31, 2021 959.00
Sep 30, 2021 220.00
Jun 30, 2021 -321.00